Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Study Information
Alliance Study ID: NCCTG-N08C9
NCT Study ID (ClinicalTrials.gov): NCT01198145
Alliance Committee: Cancer Control
Disease or Cancer Type: Other Cancer
Alliance Study Chair: Robert C. Miller, MD
Status: COMPLETED
Study Description
RATIONALE: Sulfasalazine may relieve diarrhea in patients with cancer who are undergoing pelvic radiation therapy.
PURPOSE: This randomized phase III trial is studying sulfasalazine to see how well it works in preventing acute diarrhea in patients with cancer who are undergoing pelvic radiation therapy.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information